34th Bethesda Conference: Task force #5--Is atherosclerosis imaging cost effective?

[1]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[2]  D. Berman,et al.  Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. , 2003, Radiology.

[3]  V. Fuster,et al.  Computed Tomography and Magnetic Resonance Imaging for Noninvasive Coronary Angiography and Plaque Imaging: Current and Potential Future Concepts , 2002, Circulation.

[4]  P. O'Malley,et al.  Frequency and severity of "incidentalomas" encountered during electron beam computed tomography for coronary calcium in middle-aged army personnel. , 2002, The American journal of cardiology.

[5]  O. Miettinen,et al.  Mammographic screening: no reliable supporting evidence? , 2002, The Lancet.

[6]  S. Achenbach,et al.  Influence of Lipid-Lowering Therapy on the Progression of Coronary Artery Calcification: A Prospective Evaluation , 2002, Circulation.

[7]  D. Mark,et al.  Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference. , 2002, Journal of the American College of Cardiology.

[8]  Michael Pignone,et al.  Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[9]  A. Hofman,et al.  The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis: the Rotterdam Coronary Calcification Study. , 2002, Journal of the American College of Cardiology.

[10]  R. Hayward,et al.  Perioperative cardiovascular risk stratification of patients with diabetes who undergo elective major vascular surgery. , 2002, Journal of vascular surgery.

[11]  M. Reiser,et al.  Coronary artery calcium: absolute quantification in nonenhanced and contrast-enhanced multi-detector row CT studies. , 2002, Radiology.

[12]  E Berry,et al.  The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review. , 2002, Health technology assessment.

[13]  M. Tuchman,et al.  Screening of infants and mortality due to neuroblastoma. , 2002, The New England journal of medicine.

[14]  G. Laszlo,et al.  Cost-effectiveness of diagnostic tests , 2002, The Lancet.

[15]  Ingvar Andersson,et al.  Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.

[16]  Amnon Sonnenberg,et al.  Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. , 2002, Archives of internal medicine.

[17]  G. L’italien,et al.  New National Cholesterol Education Program III Guidelines for Primary Prevention Lipid-Lowering Drug Therapy: Projected Impact on the Size, Sex, and Age Distribution of the Treatment-Eligible Population , 2002, Circulation.

[18]  L. Kuller,et al.  Coronary Artery Calcification in Older Adults to Age 99: Prevalence and Risk Factors , 2001, Circulation.

[19]  Alvin I Mushlin,et al.  Costeffectiveness of diagnostic tests , 2001, The Lancet.

[20]  Peter C Gøtzsche,et al.  Cochrane review on screening for breast cancer with mammography , 2001, The Lancet.

[21]  S M Grundy,et al.  Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. , 2001, Circulation.

[22]  M. McKenna,et al.  Importance of perspective in economic analyses of cancer screening decisions , 2001, The Lancet.

[23]  D. Gyrd-Hansen,et al.  Analysing public preferences for cancer screening programmes. , 2001, Health economics.

[24]  D. Grönemeyer,et al.  Prevalence and clinical significance of accidental findings in electron-beam tomographic scans for coronary artery calcification. , 2001, European heart journal.

[25]  V. Fuster,et al.  Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions: A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging , 2001, Circulation.

[26]  H D Banta,et al.  INTRODUCTION: MASS SCREENING, HEALTH TECHNOLOGY ASSESSMENT, AND HEALTH POLICY IN SOME EUROPEAN COUNTRIES , 2001, International Journal of Technology Assessment in Health Care.

[27]  A. Hofman,et al.  Is Carotid Intima-Media Thickness Useful in Cardiovascular Disease Risk Assessment?: The Rotterdam Study , 2001, Stroke.

[28]  T. Callister,et al.  Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial ☆ ☆☆ , 2001 .

[29]  P. Johnstone,et al.  Yield of mammography in selected patients age ≤ 30 years , 2001, Cancer.

[30]  M. Trip,et al.  Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial , 2001, The Lancet.

[31]  S. Achenbach,et al.  Variability of repeated coronary artery calcium measurements by electron beam tomography. , 2001, The American journal of cardiology.

[32]  G. Bepler,et al.  Screening for lung cancer. , 2000, The New England journal of medicine.

[33]  A. Nicolaides,et al.  Investigation of chronic venous insufficiency: A consensus statement (France, March 5-9, 1997). , 2000, Circulation.

[34]  L. Shaw,et al.  American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. , 2000, Circulation.

[35]  D. Berman,et al.  Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study Group. , 2000, The American journal of cardiology.

[36]  T. Callister,et al.  Evaluation of chest pain in patients with low to intermediate pretest probability of coronary artery disease by electron beam computed tomography. , 2000, The American journal of cardiology.

[37]  Peter C Gøtzsche,et al.  Is screening for breast cancer with mammography justifiable? , 2000, The Lancet.

[38]  M G Hunink,et al.  Noninvasive Imaging for the Diagnosis of Coronary Artery Disease: Focusing the Development of New Diagnostic Technology , 1999, Annals of Internal Medicine.

[39]  Philip Greenland,et al.  Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations , 1999 .

[40]  S M Grundy,et al.  Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 1999, Circulation.

[41]  S. Saha,et al.  Diagnosis of suspected coronary artery disease in women: A cost- effectiveness analysis , 1999 .

[42]  L E Ginzton,et al.  Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. , 1999, Circulation.

[43]  A. Garber,et al.  Cost-Effectiveness of Alternative Test Strategies for the Diagnosis of Coronary Artery Disease , 1999, Annals of Internal Medicine.

[44]  K. Kuntz,et al.  Cost-Effectiveness of Diagnostic Strategies for Patients with Chest Pain , 1999, Annals of Internal Medicine.

[45]  J. Rumberger,et al.  Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: a model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods. , 1999, Journal of the American College of Cardiology.

[46]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[47]  T. Callister,et al.  Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. , 1998, The New England journal of medicine.

[48]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[49]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[50]  W F Lawrence,et al.  Predicting Quality of Well-being Scores from the SF-36 , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[51]  A. Garber,et al.  Economic foundations of cost-effectiveness analysis. , 1997, Journal of health economics.

[52]  L. Goldman,et al.  Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels. , 1997, Circulation.

[53]  G. Diamond,et al.  Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? , 1996, The American journal of cardiology.

[54]  W. Powers,et al.  Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease. , 1996, Stroke.

[55]  M C Weinstein,et al.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[56]  Milton C. Weinstein,et al.  Recommendations for Reporting Cost-effectiveness Analyses , 1996 .

[57]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[58]  M. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[59]  T. Palen,et al.  Cervical cancer screening: American College of Preventive Medicine practice policy statement. , 1996, American journal of preventive medicine.

[60]  A. Hernigou,et al.  Cost comparison of electron beam tomography with conventional computed tomography scanning. , 1996, Academic radiology.

[61]  M A Hlatky,et al.  Task force 6: cost effectiveness of assessment and management of risk factors , 1996 .

[62]  H. Mabuchi,et al.  Noninvasive prediction of coronary atherosclerosis by quantification of coronary artery calcification using electron beam computed tomography: comparison with electrocardiographic and thallium exercise stress test results. , 1995, Journal of the American College of Cardiology.

[63]  S. Yusuf,et al.  Effect of coronary artery bypass graft surgery on survival , 1994, The Lancet.

[64]  T. Chalmers,et al.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.

[65]  Robertag . Williams,et al.  25th Bethesda Conference: Future Personnel Needs for Cardiovascular Health Care. November 15-16, 1993. , 1994, Journal of the American College of Cardiology.

[66]  L G Kessler,et al.  Cervical cancer screening: who is not screened and why? , 1991, American journal of public health.

[67]  Malcolm E. Turner,et al.  The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant Information , 1986 .

[68]  M C Weinstein,et al.  Use and misuse of the term "cost effective" in medicine. , 1986, The New England journal of medicine.

[69]  F. Harrell,et al.  Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. , 1984, The American journal of medicine.

[70]  J. Aitchison,et al.  Decision-Making in Clinical Medicine , 1970, Journal of the Royal College of Physicians of London.

[71]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[72]  J. Sunshine,et al.  Recent rapid increase in utilization of radionuclide myocardial perfusion imaging and related procedures: 1996-1998 practice patterns. , 2002, Radiology.

[73]  L. Erhardt,et al.  Reassessing European Attitudes about Cardiovascular Treatment (REACT) - General population survey , 2000 .

[74]  A H Briggs,et al.  Handling uncertainty when performing economic evaluation of healthcare interventions. , 1999, Health technology assessment.

[75]  A. Culyer,et al.  A systematic literature review of spiral and electron beam computed tomography: with particular reference to clinical applications in hepatic lesions, pulmonary embolus and coronary artery disease. , 1999, Health technology assessment.

[76]  S. Hampson,et al.  The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. , 1999, Health technology assessment.

[77]  J A Brebner,et al.  When and how to assess fast-changing technologies: a comparative study of medical applications of four generic technologies. , 1997, Health technology assessment.

[78]  J. Kirklin.  ACC/AHA guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery). , 1991, Circulation.

[79]  W. C. Sheldon,et al.  Guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery). , 1991, Journal of the American College of Cardiology.

[80]  M. Weinstein,et al.  Cost-effectiveness of interventions to prevent or treat coronary heart disease. , 1985, Annual review of public health.

[81]  D. Cox.  Regression Models and Life-Tables , 1972 .